Skip to main navigation Skip to search Skip to main content

What is new in the battle against postoperative nausea and vomiting?

  • Stony Brook University

Research output: Contribution to journalReview articlepeer-review

39 Scopus citations

Abstract

The issue of postoperative nausea and vomiting (PONV) still poses a significant burden on our patients. Although rarely associated with a life-threatening condition, it is consistently considered as one of the most undesirable side effects of surgery and anesthesia. There are well-established risk factors for the development of PONV that include patient-related factors, anesthetic technique, use of volatile anesthetics, use of nitrous oxide, duration of anesthesia, opioid administration, and type of surgery. Because pharmacologic interventions for PONV are not without risks, practitioners must assess patient's risk status from low to high and consider the benefits of treatment. This review summarizes the current state of knowledge related to PONV and provides a practical approach toward risk assessment, prevention, and numerous treatment strategies.

Original languageEnglish
Pages (from-to)137-148
Number of pages12
JournalBest Practice and Research: Clinical Anaesthesiology
Volume32
Issue number2
DOIs
StatePublished - Jun 2018

Keywords

  • dopamine antagonists
  • NK-1 receptor antagonists
  • PONV combination therapy
  • PONV treatment strategies
  • postoperative nausea and vomiting (PONV) risk assessment
  • serotonin receptor antagonists

Fingerprint

Dive into the research topics of 'What is new in the battle against postoperative nausea and vomiting?'. Together they form a unique fingerprint.

Cite this